Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

NCT00004933 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Leukemia

Interventions

DRUG: hydroxyurea
DRUG: Homoharringtonine

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]